Jeisys Medical Statistics

Total Valuation

Jeisys Medical has a market cap or net worth of KRW 974.74 billion. The enterprise value is 965.85 billion.

Market Cap	974.74B
Enterprise Value	965.85B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Jeisys Medical has 75.56 million shares outstanding. The number of shares has increased by 0.33% in one year.

Current Share Class	n/a
Shares Outstanding	75.56M
Shares Change (YoY)	+0.33%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.55%
Float	n/a

Valuation Ratios

The trailing PE ratio is 35.64 and the forward PE ratio is 19.93.

PE Ratio	35.64
Forward PE	19.93
PS Ratio	5.88
PB Ratio	8.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.62, with an EV/FCF ratio of 88.78.

EV / Earnings	34.53
EV / Sales	5.76
EV / EBITDA	22.62
EV / EBIT	25.31
EV / FCF	88.78

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.62.

Current Ratio	2.00
Quick Ratio	1.53
Debt / Equity	0.62
Debt / EBITDA	1.65
Debt / FCF	6.47
Interest Coverage	111.91

Financial Efficiency

Return on equity (ROE) is 27.29% and return on invested capital (ROIC) is 16.20%.

Return on Equity (ROE)	27.29%
Return on Assets (ROA)	14.09%
Return on Capital (ROIC)	16.20%
Revenue Per Employee	610.27M
Profits Per Employee	101.71M
Employee Count	275
Asset Turnover	0.99
Inventory Turnover	2.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.59%
50-Day Moving Average	12,874.20
200-Day Moving Average	11,186.75
Relative Strength Index (RSI)	56.13
Average Volume (20 Days)	6,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeisys Medical had revenue of KRW 167.82 billion and earned 27.97 billion in profits. Earnings per share was 361.97.

Revenue	167.82B
Gross Profit	117.03B
Operating Income	38.16B
Pretax Income	38.29B
Net Income	27.97B
EBITDA	42.69B
EBIT	38.16B
Earnings Per Share (EPS)	361.97

Full Income Statement

Balance Sheet

The company has 80.78 billion in cash and 70.42 billion in debt, giving a net cash position of 10.35 billion or 137.02 per share.

Cash & Cash Equivalents	80.78B
Total Debt	70.42B
Net Cash	10.35B
Net Cash Per Share	137.02
Equity (Book Value)	112.89B
Book Value Per Share	1,475.83
Working Capital	64.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 30.24 billion and capital expenditures -19.36 billion, giving a free cash flow of 10.88 billion.

Operating Cash Flow	30.24B
Capital Expenditures	-19.36B
Free Cash Flow	10.88B
FCF Per Share	143.97

Full Cash Flow Statement

Margins

Gross margin is 69.73%, with operating and profit margins of 22.74% and 16.67%.

Gross Margin	69.73%
Operating Margin	22.74%
Pretax Margin	22.82%
Profit Margin	16.67%
EBITDA Margin	25.44%
EBIT Margin	22.74%
FCF Margin	6.48%

Dividends & Yields

Jeisys Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.33%
Shareholder Yield	-0.33%
Earnings Yield	2.81%
FCF Yield	1.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeisys Medical has an Altman Z-Score of 7.62.

Altman Z-Score	7.62
Piotroski F-Score	n/a